Biomarker Testing and Next-Generation Sequencing Inform Modern Treatment Strategies for mCRC
Dr. Bekaii-Saab shares the approach his practice takes to essential biomarker testing and next-generation sequencing in order to improve patient outcomes.
EP: 1.Recent Advancements and Current Areas of Focus in the Treatment of mCRC
EP: 2.HER2 as a Potential Drug Target and its Prevalence in GI Malignancies
Now Viewing
EP: 3.Biomarker Testing and Next-Generation Sequencing Inform Modern Treatment Strategies for mCRC
EP: 4.MOUNTAINEER Trial: Rationale, Results and Clinical Implications
EP: 5.Promising Early Data from GI Malignancy Trials
Related Videos
Related Content
